MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
AUPH Aurinia Pharmaceuticals
- 9.030
- -0.010-0.11%
Close Dec 20 16:00 ET
- 9.030
- 0.0000.00%
Post 20:01 ET
1.29BMarket Cap-60.20P/E (TTM)
9.230High8.920Low1.58MVolume8.950Open9.040Pre Close14.35MTurnover1.20%Turnover RatioLossP/E (Static)143.18MShares10.67052wk High3.33P/B1.19BFloat Cap4.71052wk Low--Dividend TTM131.70MShs Float33.972Historical High--Div YieldTTM3.43%Amplitude1.000Historical Low9.059Avg Price1Lot Size
Aurinia Pharmaceuticals Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 21, 2024
The average Aurinia Pharmaceuticals stock price target is 10.28 with a max estimate of 11.00 and a min estimate of 9.00
Review Aurinia Pharmaceuticals earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 21, 2024